Human papillomavirus oncogenic E6 protein regulates human β-defensin 3 (hBD3) expression via the tumor suppressor protein p53

Twishasri DasGupta, Emeka I. Nweze, Hong Yue, Liming Wang, Jessica Jin, Santosh K. Ghosh, Hameem I. Kawsar, Chad Zender, Elliot Androphy, Aaron Weinberg, Thomas S. McCormick, Ge Jin

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Human β-defensin-3 (hBD3) is an epithelial cell-derived innate immune regulatory molecule overexpressed in oral dysplastic lesions and fosters a tumorpromoting microenvironment. Expression of hBD3 is induced by the epidermal growth factor receptor signaling pathway. Here we describe a novel pathway through which the high-risk human papillomavirus type-16 (HPV-16) oncoprotein E6 induces hBD3 expression in mucosal keratinocytes. Ablation of E6 by siRNA induces the tumor suppressor p53 and diminishes hBD3 in HPV-16 positive CaSki cervical cancer cells and UM-SCC-104 head and neck cancer cells. Malignant cells in HPV-16-associated oropharyngeal cancer overexpress hBD3. HPV-16 E6 induces hBD3 mRNA expression, peptide production and gene promoter activity in mucosal keratinocytes. Reduction of cellular levels of p53 stimulates hBD3 expression, while activation of p53 by doxorubicin inhibits its expression in primary oral keratinocytes and CaSki cells, suggesting that p53 represses hBD3 expression. A p53 binding site in the hBD3 gene promoter has been identified by using electrophoretic mobility shift assays and chromatin immunoprecipitation (ChIP). In addition, the p63 protein isoform ΔNp63α, but not TAp63, stimulated transactivation of the hBD3 gene and was coexpressed with hBD3 in head and neck cancer specimens. Therefore, high-risk HPV E6 oncoproteins may stimulate hBD3 expression in tumor cells to facilitate tumorigenesis of HPV-associated head and neck cancer.

Original languageEnglish (US)
Pages (from-to)27430-27444
Number of pages15
JournalOncotarget
Volume7
Issue number19
DOIs
StatePublished - May 10 2016

Fingerprint

Defensins
Tumor Suppressor Protein p53
Human papillomavirus 16
Head and Neck Neoplasms
Keratinocytes
Oncogene Proteins
Proteins
Oropharyngeal Neoplasms
Genes
Chromatin Immunoprecipitation
Electrophoretic Mobility Shift Assay
Epidermal Growth Factor Receptor
Uterine Cervical Neoplasms
Doxorubicin
Small Interfering RNA
Transcriptional Activation
Neoplasms
Protein Isoforms
Carcinogenesis
Epithelial Cells

Keywords

  • Head and neck cancer
  • Human papillomavirus
  • Human β-defensins
  • Microenvironment
  • p53

ASJC Scopus subject areas

  • Oncology

Cite this

Human papillomavirus oncogenic E6 protein regulates human β-defensin 3 (hBD3) expression via the tumor suppressor protein p53. / DasGupta, Twishasri; Nweze, Emeka I.; Yue, Hong; Wang, Liming; Jin, Jessica; Ghosh, Santosh K.; Kawsar, Hameem I.; Zender, Chad; Androphy, Elliot; Weinberg, Aaron; McCormick, Thomas S.; Jin, Ge.

In: Oncotarget, Vol. 7, No. 19, 10.05.2016, p. 27430-27444.

Research output: Contribution to journalArticle

DasGupta, T, Nweze, EI, Yue, H, Wang, L, Jin, J, Ghosh, SK, Kawsar, HI, Zender, C, Androphy, E, Weinberg, A, McCormick, TS & Jin, G 2016, 'Human papillomavirus oncogenic E6 protein regulates human β-defensin 3 (hBD3) expression via the tumor suppressor protein p53', Oncotarget, vol. 7, no. 19, pp. 27430-27444. https://doi.org/10.18632/oncotarget.8443
DasGupta, Twishasri ; Nweze, Emeka I. ; Yue, Hong ; Wang, Liming ; Jin, Jessica ; Ghosh, Santosh K. ; Kawsar, Hameem I. ; Zender, Chad ; Androphy, Elliot ; Weinberg, Aaron ; McCormick, Thomas S. ; Jin, Ge. / Human papillomavirus oncogenic E6 protein regulates human β-defensin 3 (hBD3) expression via the tumor suppressor protein p53. In: Oncotarget. 2016 ; Vol. 7, No. 19. pp. 27430-27444.
@article{a445772e8c46415da68fdfa123f36315,
title = "Human papillomavirus oncogenic E6 protein regulates human β-defensin 3 (hBD3) expression via the tumor suppressor protein p53",
abstract = "Human β-defensin-3 (hBD3) is an epithelial cell-derived innate immune regulatory molecule overexpressed in oral dysplastic lesions and fosters a tumorpromoting microenvironment. Expression of hBD3 is induced by the epidermal growth factor receptor signaling pathway. Here we describe a novel pathway through which the high-risk human papillomavirus type-16 (HPV-16) oncoprotein E6 induces hBD3 expression in mucosal keratinocytes. Ablation of E6 by siRNA induces the tumor suppressor p53 and diminishes hBD3 in HPV-16 positive CaSki cervical cancer cells and UM-SCC-104 head and neck cancer cells. Malignant cells in HPV-16-associated oropharyngeal cancer overexpress hBD3. HPV-16 E6 induces hBD3 mRNA expression, peptide production and gene promoter activity in mucosal keratinocytes. Reduction of cellular levels of p53 stimulates hBD3 expression, while activation of p53 by doxorubicin inhibits its expression in primary oral keratinocytes and CaSki cells, suggesting that p53 represses hBD3 expression. A p53 binding site in the hBD3 gene promoter has been identified by using electrophoretic mobility shift assays and chromatin immunoprecipitation (ChIP). In addition, the p63 protein isoform ΔNp63α, but not TAp63, stimulated transactivation of the hBD3 gene and was coexpressed with hBD3 in head and neck cancer specimens. Therefore, high-risk HPV E6 oncoproteins may stimulate hBD3 expression in tumor cells to facilitate tumorigenesis of HPV-associated head and neck cancer.",
keywords = "Head and neck cancer, Human papillomavirus, Human β-defensins, Microenvironment, p53",
author = "Twishasri DasGupta and Nweze, {Emeka I.} and Hong Yue and Liming Wang and Jessica Jin and Ghosh, {Santosh K.} and Kawsar, {Hameem I.} and Chad Zender and Elliot Androphy and Aaron Weinberg and McCormick, {Thomas S.} and Ge Jin",
year = "2016",
month = "5",
day = "10",
doi = "10.18632/oncotarget.8443",
language = "English (US)",
volume = "7",
pages = "27430--27444",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "19",

}

TY - JOUR

T1 - Human papillomavirus oncogenic E6 protein regulates human β-defensin 3 (hBD3) expression via the tumor suppressor protein p53

AU - DasGupta, Twishasri

AU - Nweze, Emeka I.

AU - Yue, Hong

AU - Wang, Liming

AU - Jin, Jessica

AU - Ghosh, Santosh K.

AU - Kawsar, Hameem I.

AU - Zender, Chad

AU - Androphy, Elliot

AU - Weinberg, Aaron

AU - McCormick, Thomas S.

AU - Jin, Ge

PY - 2016/5/10

Y1 - 2016/5/10

N2 - Human β-defensin-3 (hBD3) is an epithelial cell-derived innate immune regulatory molecule overexpressed in oral dysplastic lesions and fosters a tumorpromoting microenvironment. Expression of hBD3 is induced by the epidermal growth factor receptor signaling pathway. Here we describe a novel pathway through which the high-risk human papillomavirus type-16 (HPV-16) oncoprotein E6 induces hBD3 expression in mucosal keratinocytes. Ablation of E6 by siRNA induces the tumor suppressor p53 and diminishes hBD3 in HPV-16 positive CaSki cervical cancer cells and UM-SCC-104 head and neck cancer cells. Malignant cells in HPV-16-associated oropharyngeal cancer overexpress hBD3. HPV-16 E6 induces hBD3 mRNA expression, peptide production and gene promoter activity in mucosal keratinocytes. Reduction of cellular levels of p53 stimulates hBD3 expression, while activation of p53 by doxorubicin inhibits its expression in primary oral keratinocytes and CaSki cells, suggesting that p53 represses hBD3 expression. A p53 binding site in the hBD3 gene promoter has been identified by using electrophoretic mobility shift assays and chromatin immunoprecipitation (ChIP). In addition, the p63 protein isoform ΔNp63α, but not TAp63, stimulated transactivation of the hBD3 gene and was coexpressed with hBD3 in head and neck cancer specimens. Therefore, high-risk HPV E6 oncoproteins may stimulate hBD3 expression in tumor cells to facilitate tumorigenesis of HPV-associated head and neck cancer.

AB - Human β-defensin-3 (hBD3) is an epithelial cell-derived innate immune regulatory molecule overexpressed in oral dysplastic lesions and fosters a tumorpromoting microenvironment. Expression of hBD3 is induced by the epidermal growth factor receptor signaling pathway. Here we describe a novel pathway through which the high-risk human papillomavirus type-16 (HPV-16) oncoprotein E6 induces hBD3 expression in mucosal keratinocytes. Ablation of E6 by siRNA induces the tumor suppressor p53 and diminishes hBD3 in HPV-16 positive CaSki cervical cancer cells and UM-SCC-104 head and neck cancer cells. Malignant cells in HPV-16-associated oropharyngeal cancer overexpress hBD3. HPV-16 E6 induces hBD3 mRNA expression, peptide production and gene promoter activity in mucosal keratinocytes. Reduction of cellular levels of p53 stimulates hBD3 expression, while activation of p53 by doxorubicin inhibits its expression in primary oral keratinocytes and CaSki cells, suggesting that p53 represses hBD3 expression. A p53 binding site in the hBD3 gene promoter has been identified by using electrophoretic mobility shift assays and chromatin immunoprecipitation (ChIP). In addition, the p63 protein isoform ΔNp63α, but not TAp63, stimulated transactivation of the hBD3 gene and was coexpressed with hBD3 in head and neck cancer specimens. Therefore, high-risk HPV E6 oncoproteins may stimulate hBD3 expression in tumor cells to facilitate tumorigenesis of HPV-associated head and neck cancer.

KW - Head and neck cancer

KW - Human papillomavirus

KW - Human β-defensins

KW - Microenvironment

KW - p53

UR - http://www.scopus.com/inward/record.url?scp=84968865963&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84968865963&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.8443

DO - 10.18632/oncotarget.8443

M3 - Article

C2 - 27034006

AN - SCOPUS:84968865963

VL - 7

SP - 27430

EP - 27444

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 19

ER -